Literature DB >> 17389561

Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system.

Hans J Roethig1, Barbara K Zedler, Robin D Kinser, Shixia Feng, Bettie L Nelson, Qiwei Liang.   

Abstract

This randomized, controlled, forced-switching, open-label, parallel-group study in 100 adult male and female smokers of conventional cigarettes evaluated 8 biomarkers of tobacco smoke exposure. After baseline exposure determinations, adult smokers were switched to a second-generation electrically heated cigarette smoking system (EHCSS) for 8 days in a clinical setting. After 8 days of smoking the EHCSS biomarkers of exposure decreased by 43% to 85% compared to baseline. After correction for residual effects (carryover effects due to long elimination half-life and non-tobacco-confounding sources of exposure), reductions in exposure ranged from 59% to 97%. Results from this short-term clinical exposure study indicate that switching from a conventional cigarette to a second-generation electrically heated cigarette smoking system substantially reduced the exposure to several measured potentially harmful constituents of tobacco smoke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389561     DOI: 10.1177/0091270006297686

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  21 in total

1.  Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers.

Authors:  Timothy R Church; Kristin E Anderson; Chap Le; Yan Zhang; Diane M Kampa; Adam R Benoit; Andrea R Yoder; Steven G Carmella; Stephen S Hecht
Journal:  Biomarkers       Date:  2010-06       Impact factor: 2.658

2.  High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.

Authors:  Steven G Carmella; Xun Ming; Natalie Olvera; Claire Brookmeyer; Andrea Yoder; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2013-07-24       Impact factor: 3.739

3.  Role of endoplasmic reticulum stress in acrolein-induced endothelial activation.

Authors:  Petra Haberzettl; Elena Vladykovskaya; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-07       Impact factor: 4.219

Review 4.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 5.  Methods used in internal industry clinical trials to assess tobacco risk reduction.

Authors:  Vaughan W Rees; Jennifer M Kreslake; Richard J O'Connor; K Michael Cummings; Mark Parascandola; Dorothy Hatsukami; Peter G Shields; Gregory N Connolly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 6.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 7.  Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease.

Authors:  Jan F Stevens; Claudia S Maier
Journal:  Mol Nutr Food Res       Date:  2008-01       Impact factor: 5.914

8.  Measurement of smoking behavior: Comparison of self-reports, returned cigarette butts, and toxicant levels.

Authors:  Melissa D Blank; Alison B Breland; Paul T Enlow; Christina Duncan; Aaron Metzger; Caroline O Cobb
Journal:  Exp Clin Psychopharmacol       Date:  2016-06-27       Impact factor: 3.157

Review 9.  Developing the science base for reducing tobacco harm.

Authors:  Dorothy K Hatsukami; Anne M Joseph; Mark Lesage; Joni Jensen; Sharon E Murphy; Paul R Pentel; Michael Kotlyar; Eugene Borgida; Chap Le; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

10.  Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages.

Authors:  Timothy E O'Toole; Yu-Ting Zheng; Jason Hellmann; Daniel J Conklin; Oleg Barski; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.